- Home
- ALX vs OPK Comparison
ALX vs OPK Comparison
Compare ALX & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALX
- OPK
- Stock Information
- Founded
- ALX 1928
- OPK 2007
- Country
- ALX United States
- OPK United States
- Employees
- ALX N/A
- OPK N/A
- Industry
- ALX Real Estate Investment Trusts
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- ALX Real Estate
- OPK Health Care
- Exchange
- ALX Nasdaq
- OPK Nasdaq
- Market Cap
- ALX 1.1B
- OPK 1.0B
- IPO Year
- ALX N/A
- OPK 1995
- Fundamental
- Price
- ALX $191.31
- OPK $1.47
- Analyst Decision
- ALX Sell
- OPK Strong Buy
- Analyst Count
- ALX 1
- OPK 3
- Target Price
- ALX $125.00
- OPK $2.75
- AVG Volume (30 Days)
- ALX 13.9K
- OPK 2.9M
- Earning Date
- ALX 02-10-2025
- OPK 02-25-2025
- Dividend Yield
- ALX 9.37%
- OPK N/A
- EPS Growth
- ALX N/A
- OPK N/A
- EPS
- ALX 9.25
- OPK N/A
- Revenue
- ALX $233,399,000.00
- OPK $711,408,000.00
- Revenue This Year
- ALX N/A
- OPK N/A
- Revenue Next Year
- ALX N/A
- OPK $0.00
- P/E Ratio
- ALX $20.77
- OPK N/A
- Revenue Growth
- ALX 8.52
- OPK N/A
- 52 Week Low
- ALX $184.76
- OPK $0.86
- 52 Week High
- ALX $251.63
- OPK $1.76
- Technical
- Relative Strength Index (RSI)
- ALX 36.62
- OPK 44.04
- Support Level
- ALX $184.76
- OPK $1.44
- Resistance Level
- ALX $196.00
- OPK $1.55
- Average True Range (ATR)
- ALX 4.46
- OPK 0.06
- MACD
- ALX 0.41
- OPK -0.00
- Stochastic Oscillator
- ALX 38.96
- OPK 33.33
About ALX Alexander's Inc.
Alexander's Inc is a real estate investment trust engaged in leasing, managing, developing and redeveloping its properties. It has six properties in the greater New York City metropolitan area. All of the revenues come from properties located in New York City which include revenues from leasing of space to tenants at their properties and revenues from parking and tenant services.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.